Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

We found 10 resources that match your search and filter choices.

Your selections:
Clear all

Show Filters

  • HPTN Scholars

    The HIV Prevention Trials Network (HPTN) offers two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute on Drug Abuse (NIDA). The HPTN Scholars Program now includes two...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV/TB Drug Development: Chemical Synthesis

    This service provides chemical synthesis of lead compounds for use in additional drug development studies. Compounds must previously have been successfully synthesized to be candidates for this service. Synthesis of new analogs is not supported....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • IMPAACT Laboratory Center

    The main purpose of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center is to support the network’s scientific agenda by providing state of the art laboratory testing in support of clinical trials, new works concept sheets (NWCS), and data analysis...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • IMPAACT Early Career Investigator Mentored Research

    The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Early Career Investigator Mentored Research program aims to support the development of early career investigators to enter the field of maternal/child HIV research and advance the mission of the IMPAACT Network. In...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • ACTG/IMPAACT Specimen Repositories

    The specimen repositories are a collaboration between the ACTG and IMPAACT clinical trial networks to make the large body of specimens collected for HIV research available to investigators. The specimens stored at the repositories were initially collected for specific studies that have concluded,...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • ACTG Network Laboratory (ACTG NL)

    The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB. Each Core Laboratory Group is comprised of several Specialty Laboratories that provide a broad range of assays and services required to conduct the scientific agenda of the ACTG and to complement laboratory...

    coanstevensje@nih.gov - 2017-08-29 17:42

  • International Clinical Sciences Support Center (ICSSC)

    The ICSSC provides a wide range of support services to clinical investigators who are conducting international research funded by the Division of Microbiology and Infectious Diseases (DMID), including consultation and assistance to investigators for protocol development, site assessment, data...

    coanstevensje@nih.gov - 2017-08-30 12:45

  • Phase I Clinical Trial Units for Therapeutics

    The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclonal...

    coanstevensje@nih.gov - 2017-08-30 19:13

  • Vaccine and Treatment Evaluation Units (VTEUs) Services

    The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of contracts with academic centers and organizations that provides a ready resource for the conduct of clinical trials to evaluate...

    coanstevensje@nih.gov - 2017-09-08 14:17

  • Consortium for TB Biomarkers (CTB2) Biorepository

    The Consortium for TB Biomarkers (CTB2) has created a collaborative biobank in order to accelerate the development of new drugs and treatments for tuberculosis by validating and exploring biomarkers of response to TB drug treatments.  The biobank will ultimately house biospecimens from 1000 adult...

    coanstevensje@nih.gov - 2017-10-03 18:18